Dendrimers bind antioxidant polyphenols and cisplatin drug

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Abderrezak, Amine ^a   Bourassa, Philippe ^a   Mandeville, Jean Sebastian ^a   Sedaghat Herati, Reza ^b   Tajmir Riahi, Heidar Ali ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^b MISSOURI STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CURCUMIN; DENDRIMER; GENISTEIN; MACROGOL; POLYAMIDOAMINE; RESVERATROL; ANTIOXIDANT; MACROGOL DERIVATIVE; MONOMETHOXYPOLYETHYLENE GLYCOL; NYLON; PAMAM G4; PAMAM-G4; POLYPHENOL; STILBENE DERIVATIVE;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; CONTROLLED STUDY; DRUG STABILITY; HYDROPHILICITY; HYDROPHOBICITY; MOLECULAR MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; INFRARED SPECTROSCOPY; METHODOLOGY; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTIOXIDANTS; CISPLATIN; CURCUMIN; DENDRIMERS; DRUG DELIVERY SYSTEMS; GENISTEIN; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NYLONS; POLYETHYLENE GLYCOLS; POLYPHENOLS; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STILBENES;

EID: 84858119036     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033102     Document Type: Article

References (41)

1. Galeazzi S, Hermans TM, Paolino M, Anzini M, Mennuni L, et al. (2010) Multivalent supramolecular dendrimer-based drugs. Biomacromolecules 11: 182-186.
2. Hu J, Fang M, Cheng Y, Zhang J, Wu Q, et al. (2010) Host-guest chemistry of dendrimer-drug complexes. 4. An in depth look into the binding/encapsulation of guanosine monophosphate by dendrimers. J Phys Chem B 114: 7148-7157.
3. Maiti PK, Caing T, Wang G, Goddard WA, (2004) Structure of PAMAM dendrimers: Generations 1 through 11. Macromolecules 37: 6236-6254.
4. Patri AK, Majoros IJ, Baker JR, (2002) Dendritic polymer macromolecular carriers for drug delivery. Curr Opinion Chem Biol 6: 466-471.
5. Tomilia DA, (2005) Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog Polymer Sci 30: 294-324.
6. Klajnert B, Bryszewska M, (2007) Dendrimers as delivery systems in gene therapy; In: Valon CL, editors. New developments in mutation research pp. 217-240 Nova: New York Chapter 9.
7. Lee CC, Mackay JA, Frechet JMJ, Szoka FC, (2005) Designing dendrimers for biological applications. Nature Biotech 23: 1517-1526.
8. Klajnert B, Bryszewska M, (2007) Dendrimers in medeicines (2007) in: Nova Science publisher, Inc., New York.
9. Kojima C, Kono K, Maruyama K, Takagishi T, (2000) Synthesis of pollyamidoamine dendriemrs having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjugate Chem 11: 910-917.
10. Zhuo RX, Du B, Lu ZR, (1999) In vitro release of 5-flurouracil with cyclic core dendritic polymer. J Control Release 57: 249-257.
11. Kono K, Liu M, Frechet JMJ, (1999) Design of dendritic macromolecules containing folate or methotrexate residues. Bioconjugate Chem 10: 1115-1121.
12. Jansen JFGA, Meijer EW, de Brabander-van den Berg EMM, (1995) The dendritic box: shape-selective liberation of encapsulated guests. J Am Chem Soc 117: 4417-4418.
13. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, et al. (2000) Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labeled poly (amido amine) dendrimers in vivo. J Control Release 65: 133-148.
14. Fant K, Esbjorner EK, Jenkins A, Grossel MC, Lincoln P, et al. (2010) Effects of PEGylation and acetylation of PAMAM dendrimers on DNA binding, cytotoxicity and in vitro transfection efficiency. Mol Pharmaceutics 7: 1734-1746.
15. Jevprascsphant R, Penny J, Jalal R, Atwood D, McKcown N, et al. (2000) The influence of surface modifications on the cytotoxicity of PAMAM dendrimers. Int J Pharm 252: 263-266.
16. Salvioli S, Sikora E, Cooper EL, Franceschi C, (2007) Curcumin in cell death processes: A challenge for CAM of age-related pathologies. Evid Based Complememt Altern Med 4: 181-190.
17. Maheshwari RK, Singh AK, Gaddipati J, Srimal RCA, (2006) Multiple biological activities of curcumin: A short review. Life Sci 78: 2081-2087.
18. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB, (2007) Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products. Cancer Res 67: 3853-3861.
19. Rao CV, Rivenson A, Simi B, Reddy BS, (1995) Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55: 259-266.
20. Nishino H, Aoike A, (1993) Genistein arrests cell cycle progression at G2-M. Cancer Res 53: 1328-1331.
21. Win W, Cao Z, Peng X, Trush MA, Li Y, (2002) Different effects of genisten and resveratrol on oxidative DNA damage in vitro. Mutat Res 513: 113-120.
22. Cao X, Xu YX, Divine G, Janakiraman N, Chapman RA, (2002) Diparate in vitro and in vivo antilukeukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J Nutr 132: 2076-2081.
23. Delmas D, Passilly-Degrace P, Jannin B, Malik MC, Latruffe N, (2002) Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. Inter J Mol Med 10: 193-199.
24. Ahmad A, Asad SF, Singh S, Hadi SM, (2000) DNA breakage by resveratrol and Cu(II):reaction mechanism and bacteriophage inactivation. Cancer Lett 154: 29-37.
25. Takahara PM, Rosenzwelg AM, Frederick CA, Lippard SJ, (1995) Crystal structure of a double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 377: 649-652.
26. Wong E, Giandomenico CM, (1999) Current status of platinum-based antitumor Drugs. Chem Rev 99: 2451-2466.
27. Iyer J, Fleming K, Hammond PT, Paula TH, (1998) Synthesis and solution properties of new linear-dendritic diblock copolymers. Macromolecules 31: 8757-8765.
28. Froehlich E, Mandeville JS, Jenning R, Sedaghat-Herati R, Tajmir-Riahi HA, (2009) Dendrierms bind human serum albumin. J Phys Chem B 11: 6986-6993.
29. Connors K, (1987) (1987) Binding constants: The measurement of molecular complex stability, John Wiley > Sons, New York.
30. Popescu MC, Filip D, Vasile C, Cruz C, Rueff JM, Marcos M, et al. (2006) Characterization by Fourier transform infrared spectroscopy (FT-IR) and 2D IR correlation spectroscopy of PAMAM dendrimer. J Phys Chem B 110: 14198-14211.
31. Singh P, Gupta U, Asthana A, Jain NK, (2008) Folate and folate#PEG#PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Bioconjugate Chem 19: 2239-2252.
32. Ottaviani MF, Furini F, Casini A, Turro NJ, Jockusch S, et al. (2000) Formation of supermolecular structures between DNA and starburst dendrimers studied by EPR, CD, UV, and melting profiles. Macromolecules 33: 7842-7851.
33. Khopde SM, Prianarsin KI, Palit DK, Mukherjee T, (2000) Effect of solvent on the excited-state photophysical properties of curcumin. Photochem Photobiol 72: 625-631.
34. Zsila F, Bikadi Z, Simonyi M, (2004) Circular dichroism spectroscopic studies reveal pH dependent binding of curcumin in the minor groove of natural and synthetic nucleic acids. Org Biomol Chem 2: 2902-2910.
35. Pillai O, Panchagnula R, (2000) Polymers in drug delivery. Curr Opin Chem Biol 5: 447-451.
36. Jansen JFGA, Meijer EW, de Brabander-van den Berg EMM, (1994) Encapsulation of guest molecules into a dendritic box. Science 266: 1226-1229.
37. Hawke CJ, Wooley KL, Fréchet JMJ, (1999) Unimolecular micells and globular amphiphiles;dendritic macromolecules as novel recyclable solubilization agents. J Chem Soc Perkin Trans pp. 1287-1297.
38. Twyman LJ, Beezer AE, Esfand R, Dardy MJ, Michell JC, (1999) The synthesis of water soluble dendrimers and their application as possible drug delivery systems. Tetrahedron Lett 40: 1743-1746.
39. Newkome GR, Moorfield CN, Baker GR, Saunders MJ, (1991) Grossman SH. Unimolecular micelles. Angew Chem Int Ed Engl 30: 1176-1178.
40. Asthana A, Chahan AS, Diwan PV, Jain NK, (2005) Poly(amidoamine)(PAMAM) dendritic nanostructures for controlled site specific delivery of acidic anti- inflammatory active ingredient. Pharm Sci Tech 6: E536-E542.
41. Huang RQ, Qu YH, Ke WL, Zhu JH, Pei YY, et al. (2007) Efficient gene delivery targeted to the brain using a transferring-conjugated polyethyleneglycol- modified polamidoamine dendrimers. FASEB J 21: 1117-1125.